D-0925-2023 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Parsippany, NJ

FDA drug recall D-0925-2023 was initiated by Ascend Laboratories, LLC on Jul 11, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 2652 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 26, 2023
Initiation Date
Jul 11, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2652 bottles

Product description

Fingolimod Capsules, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-476-30.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide in the USA

Code information

Lot 22122841, Exp August 2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0925-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0925-2023. Report a data issue: hello@regdatalab.com.